Provenance Biopharmaceuticals

About:

Provenance is a biotechnology company focused on developing therapeutics for life-threatening diseases using its antibody technologies.

Website: http://www.provenancebio.com

Top Investors: For Good Ventures

Description:

Provenance is a clinical-stage biotechnology company focused on developing novel therapeutics for cancer and other serious, life-threatening diseases. The Company’s engineered antibody technologies promote the body’s own immune system to recognize and fight disease. Provenance is based in Waltham, Massachusetts.

Total Funding Amount:

$8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)provenancebio.com

Founders:

Jason M. Walsh, Stephen Gillies

Number of Employees:

1-10

Last Funding Date:

2019-03-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai